DocWirenews interviews CMO Tom Lendvay about the inspiration behind founding Tend and the potential impacts of the Tend CAP device for preparing FMT capsules.
Read MoreGut Microbiome startup brings on Medical Device executive to lead the company to commercialization of CAP Device
Read MoreContagion Live and Tend CMO Tom Lendvay talk about preparation methods for FMT treatments, the new approach Tend’s device offers, and how that approach is being studied at Massachusetts General Hospital.
Read MoreMD+DI talks with Tend CMO Tom Lendvay about the challenges of making capsules for FMT treatment with today’s methods and what’s possible with a better way.
Read MoreTechnology News and Tend CMO Tom Lendvay discuss treating recurrent Clostridium difficile with FMT and what’s needed to expand access to this and other potential applications of FMT.
Read MoreHealth Professional Radio interviews CMO Tom Lendvay about Tend’s work with Massachusetts General Hospital on a study comparing encapsulation methods in the treatment of recurrent Clostridium difficile infection.
Read MoreEvaluating the Comparability of CAP Device for the Delivery of FMT in Critically Ill Patients
Read More